July 24, 2015 (Montreal, QC) – The World Anti-Doping Agency (WADA) published its 2014 Testing Figures Report today, which outlines the results of all 2014 tests analyzed by WADA-accredited laboratories, including in- and out-of-competition urine, blood and blood Athlete Biological Passport (ABP) data.

“WADA is pleased to publish this Report, which offers a comprehensive reflection of global anti-doping testing figures,” said WADA President, Sir Craig Reedie. “In addition to the recent 2013 Anti-Doping Rule Violations (ADRV) Report, this data will help organizations reflect on their anti-doping programs and see where improvements can be made,” added Reedie.

The 2014 data, which is entered into the Anti-Doping Administration and Management System (ADAMS) by WADA-accredited laboratories, is broken down into four sub-reports; namely, the Laboratory Report, Sport Report, Testing Authority Report, and ABP Report-Blood Analysis.

WADA has made a number of enhancements to the 2014 Report, most notably:

• Reporting of Adverse Analytical Findings (AAFs) in each drug class by sport and discipline; and
• Enhanced categorization of sport/disciplines by Association of Summer Olympic International Federations, Association of International Olympic Winter Sports Federations, Association of IOC Recognized International Sports Federations, Alliance of Independent Members of SportAccord, International Paralympic Committee, Sports for Athletes with an Impairment, and Other Sports – Code Signatories and Other Sports.

In reading the Report, it is important to note that:

• One single result does not necessarily correspond to one athlete. Results may correspond to multiple findings regarding the same athlete or measurements performed on the same athlete; such as, in the case of longitudinal studies of testosterone.
• The number of Adverse Analytical Findings (AAFs) and Atypical Findings (ATFs) in the Report may not correspond with the number of ADRVs reported by Anti-Doping Organizations (ADOs). This is because all results are subject to a results management process conducted by ADOs, which includes matching results with Therapeutic Use Exemptions (TUEs), longitudinal studies, no case to answer or no sanction.

The 2013 ADRVs Report reveals analytical and non-analytical case and sanction information. Both the 2013 ADRVs Report and the 2014 Testing Figures Report provide powerful data that will help ADOs gain a better understanding of the global incidence of doping; and, adapt their strategies to further protect clean athletes.

To help in interpreting the 2014 Testing Figures Report, a comprehensive Questions and Answers document is available on WADA’s website here.